|
07 Sep 2008 |
OncoMune Publishes Positive Results of OCM-8054
|
|
04 Sep 2008 |
Antisoma starts phase II trial of AS1411 in renal cancer
|
|
03 Sep 2008 |
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
|
|
02 Sep 2008 |
Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
|
|
02 Sep 2008 |
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
|
|
01 Sep 2008 |
Diamyd Medical's NTDDS Technology Effective Against Diabetes Pain
|
|
26 Aug 2008 |
Novosom AG acquires exclusive license from Isis Pharmaceuticals, Inc. for CD40-targeted antisense inhibitors
|
|
25 Aug 2008 |
Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics
|
|
22 Aug 2008 |
Mesoblast's allogenic, "off the shelf", stem cells are safe and effective for cervical spine fusion
|
|
21 Aug 2008 |
Allogeneic, "Off-The-Shelf", Stem Cells Are Safe And Effective For Cervical Spine Fusion
|
|
19 Aug 2008 |
Neurologix Initiates Recruitment for Phase 2 Parkinson's Disease Trial
|
|
19 Aug 2008 |
Introgen's ADVEXIN(R) MAA Accepted for Review by European Medicines Agency
|
|
18 Aug 2008 |
Bioniche Phase III Clinical Trial in Bladder Cancer Progressing Well
|
|
14 Aug 2008 |
Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
|
|
14 Aug 2008 |
Dendreon Initiates Second of Two New Phase 2 Trials
|
|
14 Aug 2008 |
Tekmira Pharmaceuticals Announces RNAi Research Collaboration with Bristol-Myers Squibb
|
|
13 Aug 2008 |
Isis Initiates Clinical Trial of CRP Drug
|
|
13 Aug 2008 |
MDRNA, Inc. Lead Candidate Demonstrates In Vivo Efficacy against Seasonal and Pandemic Flu Strains
|
|
11 Aug 2008 |
Alnylam Forms Collaboration with Max Planck Institute to Investigate Biological Mechanisms for Cellular Uptake of RNAi Therapeutics
|
|
10 Aug 2008 |
Geron Initiates Clinical Trial of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Breast Cancer
|
|
07 Aug 2008 |
Genzyme and Isis Begin Second Phase 3 Trial of Mipomersen
|
|
06 Aug 2008 |
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
|
|
06 Aug 2008 |
Lorus Toxicology Program Supports Novel Route of Administration of the Anticancer Drug LOR-2040 in Bladder Cancer
|
|
05 Aug 2008 |
Argos Therapeutics´ Arcelis™ Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial
|
|
31 Jul 2008 |
Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
|
